| Obtained Environmental management system (ISO14001), Occupational Health and Safety Management System(ISO45001) |
2023. 06 |
| Export of treatment candidate substances for gastroesophageal reflux disease |
2023. 03 |
| Acquired certification of Anti-bribery Management System ‘ISO37001’ |
2019. 01 |
| Co-promotion with Baxter Korea |
2018. 06 |
| Established Pharmaceutical Technology Research Institute |
2018. 05 |
Established Jeil Pharma Holdings Inc
(shareholding company) |
2017. 06 |
Established Jeil&Partners Inc
(pharmaceutical distribution business) |
2016. 12 |
| Spin-off of Jeil Health Science Inc (OTC) |
2016. 11 |
| Awarded the export tower award for accomplishing 50 million USD |
2016. 10 |
| Completed building facility for solid dosage form manufacture at Baegam Factory |
2016. 08 |
| Established Jeil-Yao Pharm, a Joint Venture corporation with Yao Pharma in China |
2013. 09 |
| Co-promotion with Takeda Korea |
2013. 09 |
|
Co-promotion with Lundbeck Korea |
2012. 10 |
| R&D co-operation on a botanical drug with Gyeonggi Institute of Science and Technology |
2012. 06 |
| Baegam Factory achieved non-calamity 6 times 1920 days |
2012. 06 |
| Completed Baegam Factory extension |
2012. 03 |
|
Export Tower were awarded for accomplishing USD 30 millions |
2011. 12 |
|
New Corporate Identity was announced |
2011. 03 |
|
Awarded the export tower for accomplishing USD 20 millions |
2010. 11 |
|
 |
 |
|
|
| |
|
 |
 |
| 2005. 11 |
Awarded the export tower for accomplishing USD 10 millions |
| 2004. 04 |
Awarded Dongbaek National Medal. |
| 2003. 11 |
Awarded the export tower for accomplishing USD 5 millions |
| 2003. 08 |
Constructed new head office
(745-5 Banpo-dong, Seocho-gu, Seoul, Korea) |
| 2002. 07 |
Constructed Synthetic 3rd Plant |
| 2000. 08 |
Obtained Patent of TTS(Transdermal Therapeutic System) for Alzheimer's disease. |
|
| Obtained BGMP license (KFDA) |
1999. 05 |
| Established ancillary R&D center |
1995. 07 |
Established Korea Yamanouchi Pharmaceutical Co., Ltd.
(J/V company with Yamanouchi) |
1994. 07 |
| Obtained KGMP license for all formulation |
1994. 07 |
| Constructed new branch building in Busan |
1992. 06 |
| Established Jeil-Kirin Pharm, Inc. (J/V company with Kirin) |
1991. 05 |
Established Korea Jeil Pharmaceutical Co, Ltd.
(J/V company with Daiichi) |
1990. 07 |
|
|
 |
|
|
| |
|
|
|
| 1988. 01 |
IPO (Initial Public Offering) and listed on stock market (capital of 5 billion won). |
| 1986. 10 |
Constructed Baegam GMP Plant (117-1 Geungok-ri, Woisa-myeon, Yongin-gun, Gyeonggi-do, Korea). |
| 1983. 02 |
Established Jeil Scholarship Foundation. |
| 1982. 07 |
Established Jeil Otsuka Pharmaceutical Co., Ltd.
(J/V company with Otsuka) |
| 1981. 08 |
Authorized formation of military unit |
| 1980. 01 |
Established central R&D center. |
|
Movement to a reconstructed building
(84-1 Seocho-dong, Gangnam-gu, Seoul). |
1978. 05 |
| Renamed Jeil Pharmaceutical Co., Ltd. |
1976. 07 |
Obtained license allowing eligibility to
produce habitual drugs. |
1974. 01 |
| Launched injection. |
1973. 12 |
| Obtained manufacturing license for in compounding drugs. |
1972. 05 |
| Signed license agreement with Yamanouchi Pharmaceutical Co., Ltd., Japan. |
1972. 03 |
| Signed license agreement with Daiichi Pharmaceutical Co., Ltd., Japan |
1971. 12 |
Obtained CPML
(Certificate of Pharmaceutical Manufacturing License) |
1971. 11 |
Constructed a new plant
(536-1 Yeokbuk-ri, Yongin-myeon, Gyeonggi-do). |
1971. 10 |
| Obtained import and export license for drugs, quasi drugs, cosmetics, medical instruments, and hygiene products. |
1971. 04 |
|
|
 |
|
|
| |
|
 |
|
| 1968. 05 |
Obtained import and export license for animal drugs. |
| 1961. 01 |
Obtained import and export license for pharmaceuticals. |
| 1959. 03 |
Established Jeil Pharmaceutical Industry Corporation. |
|
